Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pfister

Showing results (151-160 of 288) with videos related to

Pageof 29
Sort By:
Head & Neck|October 28, 1998
Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongueL B Harrison, H J Lee, D G Pfister, et al.
Cancer|November 10, 2023
A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, et al.
Cancer|June 1, 1990
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Head & Neck|March 10, 2018
Patterns of recurrence in oral tongue cancer with perineural invasionJennifer R Cracchiolo, Bin Xu, Jocelyn C Migliacci, et al.
Skull Base Surgery|January 1, 1994
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionationL B Harrison, D G Pfister, D Kraus, et al.
Head & Neck|September 1, 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancerM J Zelefsky, D H Kraus, D G Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacyMichelle L Klem, James G Mechalakos, Suzanne L Wolden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intentIman Osman, Eric Sherman, Bhuvanesh Singh, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.
Pageof 29

Showing results (151-160 of 288) with videos related to

Sort By:
Pageof 29
Head & Neck|October 28, 1998
Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongueL B Harrison, H J Lee, D G Pfister, et al.
Cancer|November 10, 2023
A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104)Alan L Ho, Nathan R Foster, Shyamprasad Deraje Vasudeva, et al.
Cancer|June 1, 1990
Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Head & Neck|March 10, 2018
Patterns of recurrence in oral tongue cancer with perineural invasionJennifer R Cracchiolo, Bin Xu, Jocelyn C Migliacci, et al.
Skull Base Surgery|January 1, 1994
Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionationL B Harrison, D G Pfister, D Kraus, et al.
Head & Neck|September 1, 1996
Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancerM J Zelefsky, D H Kraus, D G Pfister, et al.
International Journal of Radiation Oncology, Biology, Physics|November 6, 2007
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacyMichelle L Klem, James G Mechalakos, Suzanne L Wolden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intentIman Osman, Eric Sherman, Bhuvanesh Singh, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic CarcinomaVatche Tchekmedyian, Eric J Sherman, Lara Dunn, et al.
Pageof 29